TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
TWD 10.9
(-3.11%)
TWD 10.9
(-3.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 123.13 Million | 36.23 Million | 1.29 Billion | 23.42 Million | 20.31 Million | 29.61 Million |
| Cost of Revenue | 11.44 Million | 3.73 Million | 12.72 Million | 4.03 Million | 7.6 Million | 3.56 Million |
| Gross Profit | 111.68 Million | 32.49 Million | 1.28 Billion | 19.38 Million | 12.71 Million | 26.05 Million |
| Operating Expenses | 258.77 Million | 310.16 Million | 382.34 Million | 326.7 Million | 289.84 Million | 284.45 Million |
| Selling, General and Administrative Expenses | 98.9 Million | 72.64 Million | 99.06 Million | 77.26 Million | 66.28 Million | 86.9 Million |
| Research and Development Expenses | 187.48 Million | 237.52 Million | 283.28 Million | 249.43 Million | 223.55 Million | 197.54 Million |
| Other Expenses | - | 9000.00 | 41 Thousand | - | 153.89 Million | 328 Thousand |
| Cost and Expenses | 297.83 Million | 313.9 Million | 395.06 Million | 330.74 Million | 297.44 Million | 288.01 Million |
| Operating Income | -174.69 Million | -217.15 Million | 876.24 Million | -403.78 Million | -287.03 Million | -258.39 Million |
| Interest Expense | 1.13 Million | 854 Thousand | 244 Thousand | 601 Thousand | 1.03 Million | - |
| Income Tax Expense | 6.75 Million | 7.39 Million | 100.37 Million | -2.05 Million | 5.51 Million | -84.81 Million |
| Earnings before Tax | 143.48 Million | -229.76 Million | 875.99 Million | -406.87 Million | -290.17 Million | -343.21 Million |
| Net Income | 136.73 Million | -237.16 Million | 775.61 Million | -404.81 Million | -295.68 Million | -343.21 Million |
| Earnings Per Share Basic | 0.19 | -0.33 | 1.08 | -0.56 | -0.41 | -0.48 |
| Earnings Per Share Diluted | 0.19 | -0.33 | 1.08 | -0.56 | -0.41 | -0.48 |
| Weighted Average Shares Outstanding | 716.89 Million | 716.84 Million | 716.84 Million | 716.84 Million | 716.8 Million | 716.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 717.27 Million | 716.84 Million | 717.36 Million | 716.84 Million | 716.8 Million | 716.76 Million |
| Gross Margin | 0.91 | 0.90 | 0.99 | 0.83 | 0.63 | 0.88 |
| EBIT Margin | 1.40 | -5.21 | 0.70 | -15.90 | -12.44 | -8.38 |
| Profit Margin | 1.11 | -6.55 | 0.60 | -17.28 | -14.56 | -11.59 |
| EBITDA | 172.23 Million | -200.36 Million | 928.34 Million | -261.8 Million | -264.94 Million | -332.24 Million |
| Earnings Before Tax Margin | -1.42 | -5.99 | 0.68 | -17.24 | -14.13 | -8.72 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 121.48 Million | 10.06 Million | 123.13 Million | 8.59 Million | 9.31 Million | 99.46 Million |
| Cost of Revenue | 4.11 Million | 10.05 Million | 39.05 Million | 8.47 Million | 3.55 Million | 3.27 Million |
| Gross Profit | 117.37 Million | 7000.00 | 84.08 Million | 122 Thousand | 5.75 Million | 96.19 Million |
| Operating Expenses | 67.64 Million | 58.81 Million | 258.77 Million | 85.38 Million | 70.18 Million | 67.39 Million |
| Selling, General and Administrative Expenses | 26.72 Million | 18.64 Million | - | 25.96 Million | 21.62 Million | 21.39 Million |
| Research and Development Expenses | 40.92 Million | 40.17 Million | - | 59.42 Million | 48.55 Million | 46 Million |
| Other Expenses | 5000.00 | 473 Thousand | 149.39 Million | 149.34 Million | 3000.00 | 41 Thousand |
| Cost and Expenses | 71.76 Million | 68.86 Million | 297.83 Million | 93.85 Million | 73.73 Million | 70.67 Million |
| Operating Income | 65.01 Million | -58.8 Million | -174.69 Million | -85.26 Million | -8.32 Million | 18.22 Million |
| Interest Expense | 367 Thousand | 388 Thousand | 1.13 Million | 410 Thousand | 430 Thousand | 138 Thousand |
| Income Tax Expense | 5.58 Million | 6.29 Million | 6.75 Million | -1.52 Million | 6.65 Million | 8.27 Million |
| Earnings before Tax | 69.79 Million | -6.16 Million | 143.48 Million | 184.15 Million | -8.55 Million | 18.27 Million |
| Net Income | 64.2 Million | -6.16 Million | 136.73 Million | 185.67 Million | -8.55 Million | 10 Million |
| Earnings Per Share Basic | 0.09 | -0.01 | - | 0.26 | -0.01 | 0.01 |
| Earnings Per Share Diluted | 0.09 | -0.01 | - | 0.26 | -0.01 | 0.01 |
| Weighted Average Shares Outstanding | 713.43 Million | 717.31 Million | 716.89 Million | 717.84 Million | 716.84 Million | 716.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 713.43 Million | 717.31 Million | 717.27 Million | 717.84 Million | 716.84 Million | 716.84 Million |
| Gross Margin | 0.97 | 0.00 | 0.68 | 0.01 | 0.62 | 0.97 |
| EBIT Margin | 0.59 | -5.21 | - | -9.18 | -0.18 | 0.26 |
| Profit Margin | 0.53 | -0.61 | 1.11 | 21.61 | -0.92 | 0.10 |
| EBITDA | 71.36 Million | -52.47 Million | - | -78.83 Million | -1.71 Million | 25.68 Million |
| Earnings Before Tax Margin | 0.54 | -5.84 | -1.42 | -9.92 | -0.89 | 0.18 |
ENT
5347
VALUE
ENI1
AEI
BSIG